Welcome to CDC Stacks | Medicines for the prevention of malaria while traveling - Atovaquone-proguanil (Malarone™) - 27958 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Medicines for the prevention of malaria while traveling - Atovaquone-proguanil (Malarone™)
  • Published Date:
    1/8/13
  • Language:
    English
Filetype[PDF - 585.11 KB]


Details:
  • Corporate Authors:
    Center for Global Health (U.S.). Division of Parasitic Diseases and Malaria.
  • Description:
    What is atovaquone-proguanil? -- Who can take atovaquone-proguanil? -- Who should not take atovaquone-proguanil? -- How should I take atovaquone-proguanil? -- In what parts of the world can atovaquone-proguanil be used for prevention of malaria in travelers? -- Where can I buy atovaquone-proguanil? -- Will atovaquone-proguanil interact with my other medications? -- What are the potential side effects of atovaquone-proguanil? -- Other considerations -- How long is it safe to use atovaquone-proguanil? -- For more information.

    Atovaquone-proguanil is a combination of two drugs, atovaquone and proguanil, in a single tablet. It is available in the United States by prescription only. It is sold under the brand name Malarone and it is also soldas a generic medicine in two sizes:

    Adult tablet: 250mg atovaquone plus 100mg proguanil

    Pediatric tablet: 62.5mg atovaquone plus 25mg proguanil Atovaquone-proguanil can be prescribed for either prevention or treatment of malaria.

    This fact sheet provides information about its use for the prevention of malaria infection associated with travel.

    CS237187-D

  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like: